Uncategorized

Poolbeg Pharma, a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces a change to its Board of Directors.

Fujirebio Holdings, Inc. and Sysmex Corporation announced that they have entered into an agreement to expand their Contract Development and Manufacturing Organization partnership for Sysmex’s Automated Immunoassay System HISCL™-Series to include the field of neurodegenerative diseases, following the discussion based on the Basic Agreement on Business Collaboration in the field of immunoassay signed in October

Polaris Group, announced that the first patient was successfully dosed in the Phase 2a clinical study for Non-Alcoholic Steatohepatitis.

Sensorion announces that the Company’s shareholders are invited to participate in the Combined General Meeting, to be held on Wednesday, December 20, 2023, at 2 pm CET in the premises of the hotel Square Louvois, located at 12, rue de Louvois, 75002, Paris, France.

Despite recent layoffs and closures in the state, there are still many companies actively recruiting for roles in California.

Consider each company using three different criteria: its match with the candidate’s “why,” its financial health and its employee reviews.

The system provides immediate notifications to support the triaging of emergency room patients.

Medicaid enrollees are more likely to understand and be satisfied with their plans, despite reporting poorer health outcomes, according to a new report from KFF. 

The merger would have major effects for the makeup of the U.S. health insurance industry, and would almost certainly face a regulatory challenge.

Medical costs will continue to rise over the next few years, according to WTW. Surveyed insurers blamed expensive medical technologies and an overuse of health services.